Electroacupuncture at 5/100 Hz alleviates neuropathic pain in rats by inhibiting the CCL3/CCR5 axis in the spinal cord

Abstract

Objective:

Typically, neuropathic pain (NP) is difficult to manage as it is refractory to conventional medications. Electroacupuncture (EA) at 5/100 Hz has emerged as an effective and promising treatment for NP; however, its mechanism of action is still uncertain. Accordingly, this study investigated the alleviatory mechanism of EA in chronic compression injury (CCI)-induced chronic pain via the C–C chemokine ligand 3 / C–C chemokine receptor type 5 (CCL3/CCR5) axis.

Methods:

The CCI model was established in rats to induce NP. Mechanical and thermal hyperalgesia were assessed with von Frey and Hargreaves tests, respectively. From day 8 after CCI, EA (5/100 Hz) was performed for 1 week (30 min/day). CCL3 and CCR5 expression was detected with Western blotting and immunofluorescence. Glial cell activation was determined through co-labeling of neurons and glial cells with antibodies against CCL3 and CCR5. The release of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α was tested with enzyme-linked immunosorbent assay (ELISA).

Results:

EA markedly ameliorated CCI-induced chronic NP in rats and reduced CCL3 and CCR5 expression in the rat spinal cord. CCL3 and CCR5 were co-expressed by neurons and microglia in the central nervous system. In addition, EA also repressed the activation of glial cells and levels of IL-1β, IL-6 and TNF-α.

Conclusion:

EA may mitigate chronic NP in rats by blocking the CCL3/CCR5 axis in the spinal cord. In addition, EA appeared to exert anti-inflammatory and analgesic effects by suppressing glial cell activation. These findings add to our understanding of the mechanism of EA-induced analgesia.

Keywords

CCL3 CCR5 electroacupuncture glial cells neuropathic pain proinflammatory factors

Get full access to this article

View all access options for this article.

References

Colloca

Ludman

Bouhassira

, et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3: 17002.

Alles

SRA

Smith

. Etiology and pharmacology of neuropathic pain. Pharmacol Rev 2018; 70(2): 315–347.

Yuan

Wen

, et al. Contribution of dorsal root ganglion octamer transcription factor 1 to neuropathic pain after peripheral nerve injury. Pain 2019; 160(2): 375–384.

Kiguchi

Maeda

Kobayashi

, et al. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain 2010; 149(2): 305–315.

Sun

Chen

Lin

, et al. Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain. Mol Immunol 2016; 77: 184–192.

Kwiatkowski

Piotrowska

Rojewska

, et al. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats. Prog Neuropsychopharmacol Biol Psychiatry 2016; 64: 68–78.

Dutta

Lunzer

Auger

, et al. A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance. Arthritis Res Ther 2018; 20: 154.

Zheng

, et al. Electroacupuncture alleviates mechanical allodynia in a rat model of complex regional pain syndrome type-I via suppressing spinal CXCL12/CXCR4 signaling. J Pain 2020; 21(9–10): 1060–1074.

Fang

, et al. Inhibition of chemokine CX3CL1 in spinal cord mediates the electroacupuncture-induced suppression of inflammatory pain. J Pain Res 2019; 12: 2663–2672.

10.

Meng

Zhang

, et al. The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy. Brain Res 2011; 1414: 58–65.

11.

Kong

Puetz

Tian

, et al. Effect of electroacupuncture vs sham treatment on change in pain severity among adults with chronic low back pain: a randomized clinical trial. JAMA Netw Open 2020; 3: e2022787.

12.

Zhang

Dai

Liang

, et al. Involvement of adenosine A1 receptor in electroacupuncture-mediated inhibition of astrocyte activation during neuropathic pain. Arq Neuropsiquiatr 2018; 76(11): 736–742.

13.

Wang

, et al. Repeated electroacupuncture treatment attenuated hyperalgesia through suppression of spinal glial activation in chronic neuropathic pain rats. BMC Complement Altern Med 2018; 18: 74.

14.

Bennett

Xie

YK.

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33(1): 87–107.

15.

Bonin

Bories

De Koninck

A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments. Mol Pain 2014; 10: 26.

16.

Hargreaves

Dubner

Brown

, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32(1): 77–88.

17.

Cheng

Chen

Hsu

, et al. Loganin prevents CXCL12/CXCR4-regulated neuropathic pain via the NLRP3 inflammasome axis in nerve-injured rats. Phytomedicine 2021; 92: 153734.

18.

Berta

Nedergaard

Glia and pain: is chronic pain a gliopathy. Pain 2013; 154(Suppl. 1): S10–S28.

19.

Raghuraman

Xie

Giacobassi

, et al. Chronicling changes in the somatosensory neurons after peripheral nerve injury. Proc Natl Acad Sci USA 2020; 117: 26414–26421.

20.

Arman

Deng

Goldys

, et al. In vivo intrathecal IL-1beta quantification in rats: monitoring the molecular signals of neuropathic pain. Brain Behav Immun 2020; 88: 442–450.

21.

Chamessian

Zhang

YQ.

Pain regulation by non-neuronal cells and inflammation. Science 2016; 354: 572–577.

22.

Choi

Han

Beitz

, et al. Spinal interleukin-1β inhibits astrocyte cytochrome P450c17 expression which controls the development of mechanical allodynia in a mouse model of neuropathic pain. Front Mol Neurosci 2019; 12: 153.

23.

Gao

RR.

Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010; 126(1): 56–68.

24.

Zhang

Jiang

Gao

YJ.

Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cell Mol Life Sci 2017; 74(18): 3275–3291.

25.

Bannister

Sachau

Baron

, et al. Neuropathic pain: mechanism-based therapeutics. Annu Rev Pharmacol Toxicol 2020; 60: 257–274.

26.

Manni

Florenzano

Aloe

Electroacupuncture counteracts the development of thermal hyperalgesia and the alteration of nerve growth factor and sensory neuromodulators induced by streptozotocin in adult rats. Diabetologia 2011; 54(7): 1900–1908.

27.

Zhang

Lao

Ren

, et al. Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology 2014; 120(2): 482–503.

28.

Han

JS.

Acupuncture and endorphins. Neurosci Lett 2004; 361: 258–261.

29.

Ren

Dubner

Interactions between the immune and nervous systems in pain. Nat Med 2010; 16(11): 1267–1276.

30.

Nackley

Huh

, et al. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 2018; 129(2): 343–366.

31.

Matsushita

Tozaki-Saitoh

Kojima

, et al. Chemokine (C-C motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain. Anesthesiology 2014; 120(6): 1491–1503.

32.

Lee

Choi

D-Y

Jung

Y-Y

, et al. Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli. Neuropharmacology 2013; 67: 57–65.

33.

Zhang

Tian

Liang

, et al. The analgesic properties of Yu-Xue-Bi tablets in the inflammatory pain mice: by the inhibition of CCL3-mediated macrophage transmigration into the spinal cord. J Ethnopharmacol 2022; 289: 115051.

34.

Pottorf

Rotterman

McCallum

, et al. The role of microglia in neuroinflammation of the spinal cord after peripheral nerve injury. Cells 2022; 11: 2083.

35.

Wong

C-Y

Lee

P-H

, et al. Sciatic nerve stimulation alleviates acute neuropathic pain via modulation of neuroinflammation and descending pain inhibition in a rodent model. J Neuroinflammation 2022; 19: 153.

36.

Yang

Wang

Jin

, et al. Roles of crosstalk between astrocytes and microglia in triggering neuroinflammation and brain edema formation in 1,2-dichloroethane-intoxicated mice. Cells 2021; 10: 2647.